<?xml version="1.0" encoding="UTF-8"?>
<p>In April 2009, a novel inﬂuenza A(H1N1) virus [A(H1N1)pdm09] was recognized and quickly spread around the world. By June 2009, the World Health Organization (WHO) declared the start of the first twenty-first century influenza pandemic [
 <xref rid="CIT0001" ref-type="bibr">1</xref>]. It was estimated that there were 123,000∼203,000 pandemic respiratory deaths globally in the last 9 months of 2009, which was 10-fold higher than the laboratory-confirmed mortality count from WHO [
 <xref rid="CIT0002" ref-type="bibr">2</xref>]. In contrast to seasonal influenza virus, influenza A(H1N1)pdm09 virus sustained a substantially higher human-to-human transmissibility [
 <xref rid="CIT0003" ref-type="bibr">3</xref>] and caused more severe morbidity and mortality in children and young adults [
 <xref rid="CIT0001" ref-type="bibr">1</xref>]. Some influenza A(H1N1)pdm09 infected patients required hospitalization because of the unusually severe pneumonia or acute respiratory distress syndrome (ARDS), which was different from typical influenza symptoms [
 <xref rid="CIT0004" ref-type="bibr">4</xref>]. To date, influenza A(H1N1)pdm09 virus still posed a threat to public health. Moreover, disease severity has the potential to alter, especially if virus mutation occur [
 <xref rid="CIT0005" ref-type="bibr">5</xref>,
 <xref rid="CIT0006" ref-type="bibr">6</xref>].
</p>
